↓ Skip to main content

Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa

Overview of attention for article published in Journal of Cystic Fibrosis, March 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy
1 policy source
wikipedia
1 Wikipedia page

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
Published in
Journal of Cystic Fibrosis, March 2011
DOI 10.1016/j.jcf.2011.02.007
Pubmed ID
Authors

C.E. Wainwright, A.L. Quittner, D.E. Geller, C. Nakamura, J.L. Wooldridge, R.L. Gibson, S. Lewis, A.B. Montgomery

Abstract

Previous aztreonam for inhalation solution (AZLI) studies included patients with cystic fibrosis, Pseudomonas aeruginosa (PA) airway infection, and forced expiratory volume in 1s (FEV(1)) 25% to 75% predicted. This double-blind, multicenter, randomized, placebo-controlled trial enrolled patients (≥6 years) with FEV(1)>75% predicted.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 73 100%

Demographic breakdown

Readers by professional status Count As %
Other 9 12%
Researcher 9 12%
Student > Master 9 12%
Student > Ph. D. Student 8 11%
Student > Bachelor 8 11%
Other 14 19%
Unknown 16 22%
Readers by discipline Count As %
Medicine and Dentistry 33 45%
Agricultural and Biological Sciences 4 5%
Biochemistry, Genetics and Molecular Biology 3 4%
Nursing and Health Professions 3 4%
Immunology and Microbiology 3 4%
Other 11 15%
Unknown 16 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2017.
All research outputs
#5,446,994
of 25,374,647 outputs
Outputs from Journal of Cystic Fibrosis
#294
of 2,111 outputs
Outputs of similar age
#26,150
of 119,597 outputs
Outputs of similar age from Journal of Cystic Fibrosis
#3
of 10 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,111 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 119,597 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.